4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-22-015590
Director sold 1,875 shares at an average $61.36 ($115,056)
- Director acquired 1,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BOLGER JOHN C · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 1 in the form | +625 | $3.93 | $2,453 | 2,625 | D |
| 2022-03-01 | Sale : show line 2 in the form | −625 | $61.42 | $38,388 | 2,000 | D |
| 2022-03-01 | Exercise or conversion : show line 3 in the form | +625 | $5.81 | $3,631 | 2,625 | D |
| 2022-03-01 | Sale : show line 4 in the form | −625 | $61.40 | $38,376 | 2,000 | D |
| 2022-03-01 | Exercise or conversion : show line 5 in the form | +625 | $15.82 | $9,888 | 2,625 | D |
| 2022-03-01 | Sale : show line 6 in the form | −625 | $61.27 | $38,293 | 2,000 | D |
| Open-market sales · 1,875 sh · avg $61.36 · $115,056 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −625 | 313 | D |
| 2022-03-01 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −625 | 1,563 | D |
| 2022-03-01 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −625 | 2,813 | D |
Loading xslF345X03/doc4.xml…